Nothing is charged unless your provider prescribes. See pricing

Dual GIP / GLP-1 receptor agonist

Tirzepatide, provider-led.

A once-weekly medication that acts on two appetite-related hormone receptors, dosed and adjusted by your provider.

From $749 every 3 monthsNothing is charged unless your provider prescribes.
Woman walking outdoors in morning light
  • TypeCompounded (not FDA-approved) · Dual GIP / GLP-1 receptor agonist
  • FormsWeekly injection
  • Supply3-month supply
  • ShippingCold-chain, discreet packaging
What it is

About Tirzepatide.

Tirzepatide activates two receptors, GIP and GLP-1, involved in appetite and blood sugar regulation.

ZIND's version is prepared and dispensed by The Pharmacy Hub, a licensed 503A pharmacy. Compounded medications are not FDA-approved.

How it works

In plain language.

By acting on both GIP and GLP-1 pathways, tirzepatide helps signal fullness and slows stomach emptying.

Like other GLP-1 treatments, it starts at a low dose and is stepped up gradually under your provider's guidance.

Is it right for me?

It may suit you if…

Your provider makes the final call after reviewing your health history.

  • 01Adults looking for medical support with weight management
  • 02People comfortable with a once-weekly self-injection
  • 03Anyone who wants to discuss a dual-action option with a provider
What to expect

From profile to ongoing care.

  1. 1
    Build your profile

    Answer a few questions about your goals and health history. It's free and takes about two minutes.

  2. 2
    Provider review

    A licensed provider reviews your profile and decides whether this medication is appropriate for you.

  3. 3
    Your first weeks

    You begin on a low weekly dose. Stomach side effects are most common when starting or increasing a dose.

  4. 4
    Check-ins and adjustments

    Message your care team about how you feel. Your provider adjusts your plan as you go.

Products & pricing

Tirzepatide pricing.

Every product and price, as you'll see them at checkout. You're only charged if your provider prescribes.

Compounded

Compounded tirzepatide

Weekly injection

Compounded tirzepatide products and prices
ProductPrice
Tirzepatide injectable, 3-month supply Compounded$749 every 3 months

Compounded medications are not FDA-approved. The FDA does not verify their safety, effectiveness or quality.

Compare options

Weight Loss options.

Weight loss pricing
MedicationTypeFormSupply
Zepbound® (tirzepatide) FDA-approved GIP / GLP-1 receptor agonistWeekly single-dose penMonthly supply
Wegovy® (semaglutide) FDA-approved GLP-1 receptor agonistWeekly single-dose penMonthly supply
Wegovy® tablets (semaglutide) FDA-approved GLP-1 receptor agonistDaily tabletMonthly supply
Foundayo™ (orforglipron) FDA-approved GLP-1 receptor agonistDaily tabletMonthly supply
Compounded semaglutide GLP-1 receptor agonistWeekly injection3-month supply
Compounded tirzepatide You're hereDual GIP / GLP-1 receptor agonistWeekly injection3-month supply
FAQ

Tirzepatide questions, answered.

Still unsure? Build your profile and ask your provider. It's free.

Semaglutide acts on GLP-1 receptors; tirzepatide acts on both GIP and GLP-1 receptors. Your provider will help you decide which is appropriate.

No. Compounded tirzepatide is prepared and dispensed by The Pharmacy Hub, a licensed 503A pharmacy, for an individual patient, and isn't FDA-approved. The FDA does not verify the safety, effectiveness or quality of compounded drugs.

Sometimes. Your provider reviews your history and current dose before recommending a switch.

Your next step

See if Tirzepatide is right for you.

Two minutes to build your profile. A licensed provider takes it from there.

Get started
Free provider review Nothing is charged unless your provider prescribes.